Full Press Release Details
Ms. Arcila is an accounting professional with over 20 years of accounting, accounts payable, and accounts receivable experience. She is responsible for accounting operations and Accounts Payable at Immuneering.
IMRX Positive Sentiment
Damaris Arcila
Key Takeaway: Damaris Arcila is an experienced accounting professional with over two decades in the field. She oversees accounting operations and accounts payable at Immuneering, contributing significantly to the company's financial management.
Price reaction · baseline $6.73 (2025-12-26 close) · 48 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-1%
Market Sentiment Analysis
POSITIVE FACTORS
- Ms. Arcila has over 20 years of accounting experience.
- She is responsible for key accounting operations at Immuneering.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor
Frequently Asked Questions
What is Damaris Arcila's professional background?
Damaris Arcila has over 20 years of experience in accounting and finance.
What role does Ms. Arcila have at Immuneering?
She is responsible for accounting operations and accounts payable.